On August 18, at the adult vaccination clinic of Wenrong Hospital in Hengdian, 30-year-old Ms. Wu in Huashui Town was the first "early adopter" to successfully vaccinate the domestic bivalent cervical cancer vaccine. This marks the official launch of the first batch of domestic cervical cancer vaccines in Dongyang City. Since this year, domestic cervical cancer vaccines have attracted much attention and have been on the market in some places. It is understood that compared with the vaccines currently on the market in China, domestic vaccines are of international quality and cost-effective. The suitable population is 9-45 years old.
The first batch of domestically-made bivalent HPV vaccines were launched
The mother and daughter were jointly vaccinated with
. On the morning of the same day, the 38-year-old Ms. Ye also brought her 14-year-old daughter to the adult vaccination clinic of the hospital and asked for domestic HPV vaccine. They are also our city. The first batch of women vaccinated with domestically produced bivalent HPV vaccine. Checking personal information, paying fees, and receiving vaccinations, the entire process is completed within a few minutes.
Ms. Ye said that before deciding to vaccinate herself and her children with domestic cervical cancer vaccines, she carefully studied the differences between divalent, quadrivalent, and quaternary vaccines, as well as relevant information about imported and domestic vaccines. She concluded that domestically produced bivalent vaccines are as effective as imported vaccines in protecting high-risk HPV viruses, but the price is at least half cheaper, and there is no need to line up for vaccination, saving a lot of things.
HPV vaccination is a primary means of cervical cancer prevention and control.
Cervical cancer is one of the most common malignant tumors of the reproductive system in Chinese women, mainly caused by infection with human papillomavirus (HPV). The bivalent cervical cancer vaccine targets human papillomavirus (HPV) types 16 and 18. Studies have shown that cervical cancers related to these two types of virus infections account for about 70%-85 of all cervical cancers. %.
Lu Yidan, deputy director of the Department of Obstetrics and Gynecology of Hengdian Wenrong Hospital, said that cervical cancer is a preventable cancer. The means of prevention are cervical cancer vaccination and cervical cancer screening. It is generally believed that the sooner the HPV vaccine is vaccinated, the better, preferably before the first substantial contact with a woman-the main way of HPV infection is sexual transmission. Therefore, the World Health Organization defines 9-14 as the best age for vaccination. According to reports, before the domestic cervical cancer vaccine was approved, there were imported bivalent, quadrivalent and ninth-valent HPV vaccines in China, which were suitable for women aged 9-45, 20-45 and 16-26. In April 2019, Hengdian Wenrong Hospital established Dongyang's first adult vaccination clinic, and successively opened appointments for imported bivalent, quadrivalent and ninth-valent HPV vaccines. So far, 562 recipients have been vaccinated against cervical cancer, with 923 doses of vaccinations.
Compared with imported similar vaccines, the current domestic bivalent cervical cancer vaccine single cost is 329 yuan per shot, which is not only nearly half the price, but also the vaccination procedure is more optimized. , only two shots are needed for 9 to 14 years old . However, experts remind that cervical cancer vaccination is not "one-time-and-all." Cervical cancer vaccine does not produce 100% protection, and cannot replace conventional cervical cancer screening, nor can it replace other measures to prevent HPV infection and sexually transmitted diseases. Therefore, conventional cervical cancer screening cannot be ignored.
[ cervical cancer vaccine popular science time ]
Regarding HPV vaccine, you may need to know these
1. What kind of population is suitable for vaccination?
Answer: HPV vaccination is best before the woman has the first substantial contact . The US recommendation is 9~26 years old. The recommended vaccination age for the
bivalent vaccine is 9-25 years old, and the recommended vaccination age for the quadrivalent vaccine is 20~45 years old. This time, the approved nine-valent HPV vaccine for marketing is suitable for women aged 16 to 26 years old.
2. Do you want to be vaccinated if you are married or have children?
Answer: married and childbearing women may have been infected with HPV, but HPV infection is limited to the inner layer of the mucosal epithelium and will not induce a strong immune response. After a natural infection, about 50% of women can detect antibodies, but the titer is low, not enough to protect against re-infection. Therefore, it is very necessary for married and childbearing women to receive cervical cancer vaccine.
3. Can pregnant women and breastfeeding women be vaccinated? What should I do if I become pregnant after vaccination?
Answer: is not yetThere are data on vaccination of pregnant women and breastfeeding women, and cervical cancer vaccination is not recommended for pregnant women and breastfeeding women. In fact, the harm of HPV is not as great as imagined. These women can wait for a while, and it is not too late to receive HPV vaccine after the fetus is born and weaned.
No vaccine has been found to have adverse effects on the fetus. Therefore, if an unexpected pregnancy occurs within 6 months of vaccination, the pregnancy can be continued under close observation.
4. What is the difference between bivalent, quadrivalent and ninth-valent vaccines?
Answer: currently has three types of HPV vaccines on the market: bivalent, quadrivalent and ninth valence. The "valence" represents the type of virus that the vaccine can prevent. The
bivalent vaccine can prevent HPV16 and HPV18 virus infections. The
quadrivalent vaccine can prevent HPV types 6, 11, 16, and 18. The
nine-valent vaccine targets nine subtypes of HPV6, 11, 16, 18, 31, 33, 45, 52, and 58. International research data shows that the nine-valent vaccine can prevent 90% of cervical cancers.
5. Some people feel dizzy and nauseous after being vaccinated with HPV vaccine. What is the current situation of HPV vaccine adverse reaction monitoring?
Answer: Some women may experience headache, fatigue and injection local reactions, such as pain, after being vaccinated with cervical cancer vaccine. Redness, itching, numbness, etc., but data show that HPV vaccination is generally well tolerated by people aged 9-45. There are currently no vaccine-related deaths and teratogenic cases, but safety testing is still going on after the vaccine is mass-marketed.
Source: Dongyang Daily
Author: Hu Yang Hui
Editor: Jiang Zhi Li source
-
-
-
-
-
-
-
-
-
-